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a  b  s  t  r  a  c  t
The ﬁrst International Chapel Hill Consensus Conference was held in 1994. There have been
suggestions about the nomenclature of systemic vasculitis. Important categories were added
to  the classiﬁcation of vasculitis, and many changes were made for disease names in the
second Chapel Hill Consensus Conference 2012, which were not included in the Chapel
Hill  Consensus Conference 1994. The new nomenclature was introduced instead of being
referred to by many names such as Churg-Strauss and Wegener”s. New categories such as
Behc¸et”s and Cogan etc. were also added. These people are honored by the classiﬁcation.
They  contribute to science through their case studies, scientiﬁc articles, and observations.
This article reviews only eponyms present in the current classiﬁcation of vasculitis. The
aim  of this paper is to give information about scientists mentioned in the classiﬁcation of
vasculitis.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).





r  e  s  u  m  o
A primeira International Chapel Hill Consensus Conference (CHHC) ocorreu em 1994. Fizeram-
se  sugestões sobre a nomenclatura das vasculites sistêmicas. Na segunda CHHC, 2012,
adicionaram-se importantes categorias à classiﬁcac¸ão da vasculite e ﬁzeram-se várias
mudanc¸as  em nomes de doenc¸as que não estavam incluídas na CHCC 1994. Introduziu-
se  uma nova nomenclatura em vez de se usarem nomes como Churg-Strauss e Wegener.
Também foram adicionadas novas categorias, como de Behc¸et e Cogan etc. Essas pessoas
são  homenageadas pela classiﬁcac¸ão. Elas contribuíram para a ciência com seus estudosde  caso, artigos cientíﬁcos e observac¸ões. Este artigo analisa apenas epônimos presentes
na  classiﬁcac¸ão atual das vasculites. O objetivo é prestar informac¸ões sobre os cientistas
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Introduction
Systemic vasculitis is an inﬂammatory condition. The primary
inﬂammatory process involves the vessel wall of different
organs and systems, affecting blood vessels of different types
and sizes. The nomenclature and classiﬁcation of systemic
vasculitis has been a problem for researchers and clinicians
for many  years.1 There are different ways of classifying vas-
culitides that include the size of predominantly affected
vessels, type of inﬂammatory inﬁltrate (e.g. neutrophilic, lym-
phocytic), etiological agent (primary or secondary), disease
extension (single-organ vasculitis or systemic vasculitis) and
the pathophysiological mechanism involved (e.g. immune
complex deposits, ANCA). The ﬁrst International Chapel Hill
Consensus Conference (CHHC) was held in 1994.2 There was
an attempt to replace eponyms by noneponymous terms
which would represent the pathophysiologic process. Impor-
tant categories were added to the classiﬁcation of vasculitis,
and many  names of diseases were changed at the second
CHHC 2012, which were not included in the CHCC 1994.2,3 The
new nomenclature was introduced instead of being referred
to by many  names such as Churg-Strauss and Wegener’s.
The new categories were also added to the classiﬁcation
system, such as variable vessel vasculitis. These people are
honored by the classiﬁcation. They contribute to science
through their case studies, scientiﬁc articles, and observa-
tions. The article reviews only eponyms present in the current
classiﬁcation of vasculitis. The aim of this paper is to give
information about scientists mentioned in the classiﬁcation of
vasculitis.
Large  vessel  vasculitis
Takayasu  arteritis
Takayasu arteritis (TA) is a chronic, idiopathic, granulomatous
arteritis of the aorta and its branches. It is a form of large vessel
vasculitis, and usually affects younger patients (<50 years).2,3
The disease is also known as pulseless disease. Here, the name
comes from MikitoTakayasu. He was a Japanese ophthalmolo-
gist, born in 1860. Takayasu graduated from the Tokyo Imperial
University in 1887. He reported a case at the 12th Annual Meet-
ing of the Japan Ophthalmology Society.4,5 The patient had
no abnormality in her medical examination, except for pecu-
liar changes of the retinal central vessels with aortitis. In the
patient’s history, there were visual disturbances, and com-
plete loss of visual acuity with retinal abnormalities. After
presentation of this case, it was published in the Acta of the
Ophthalmic Society of Japan in 1908.6 Similar cases were reported
consequently. It was reported that the term ‘Takayasu arteri-
tis’ was ﬁrst used by Yasuzo Shinmi, and ofﬁcially namedPlease cite this article in press as: Sargin G, Senturk T. Scientiﬁc people
http://dx.doi.org/10.1016/j.rbre.2016.06.002
as ‘Takayasu arteritis’ by the researchers committee of the
Department of Health and Welfare of Japan in 1975.4,7 Mik-
itoTakayasu died in November 1938.4,5 Although, there are
other synonyms, the disease was called as Takayasu arteritis
in the nomenclature of vasculitides at the 2012 international
CHCC.3 1 6;x  x x(x x):xxx–xxx
Medium  vessel  vasculitis
Kawasaki  disease
Kawasaki disease is a medium-sized vessel vasculitis (visceral
arteries, its branches, and especially coronary arteries), and
usually occurs in young children. The disease is character-
ized by fever, erythematous rash, conjunctivitis, strawberry
tongue, lymphadenopathy, and speciﬁc desquamations.2,3
The disease name comes from Tomisaku Kawasaki. He was
a Japanese pediatrician, born in Tokyo in 1925. Kawasaki grad-
uated from the School of Medicine, Chiba University in 1948.8
He described a boy aged 4 years and 3 months with high fever,
mucocutaneous features, and cervical adenopathy in 1961,
and presented seven cases entitle ‘Non-scarlet fever desquama-
tion syndrome’ in 1962 at the Chiba Prefecture Pediatric Meeting,
and 20 cases entitle ‘Twenty cases of ocular-mucocutaneous syn-
drome’ in 1964 at the meeting of the 15th Eastern and Central
Japan Pediatric Meeting in Matsumoto.9–11 He published a clin-
ical observation of 50 patients in 1967 under the title “Acute
febrile mucocutaneous syndrome”.12 In this article, patients had
lymphoid involvement with speciﬁc desquamation of the ﬁn-
gers and toes. Later, Kawasaki et al. reported 50 cases in
September 1974 at Pediatrics entitled ‘A new infantile acute febrile
mucocutaneous lymph node syndrome prevailing in Japan’.13 He
retired from the pediatric department of Japan Red Cross
Hospital.8
Small  vessel  vasculitis
Granulomatosis  with  polyangiitis  (Wegener’s)
Granulomatosis with polyangiitis (Wegener’s) is an ANCA-
associated multifocal necrotizing granulomatous vasculitis
that affects small to medium-size vessels of the kidney, lower
and upper respiratory tract.2,3 The disease is named after
Friedrich Wegener, a German pathologist, born in 1907in Varel,
Germany.14–16 He completed his medical education in 1932,
studied at the pathology department of Kiel University.16
He was reported to be a member of the Nazi party, as was
half of German doctors during World War II.17–19 In Kiel, he
described a case with generalized angiitis, and necrotizing
granuloma of the upper and lower respiratory system, kid-
ney and spleen.14 Although he worked as a pathologist in
Lodz (a localized Jewish ghetto), there were conﬂicting reports
about where he worked in the health ofﬁce.16,19 Despite the
suspicion, Wegener was released due to lack of evidence
as a war criminal.16 It is reported that he was silent about
the events until his death.20 Wegener reported a peculiar
rhinogenic granulomatosis with marked involvement of the
arterial system and kidney, and published articles in 1936
and 1939.21,22 In these articles, the disease’s clinical and
pathological features were deﬁned. The term of ‘Wegener’s
granulomatosis’ was ﬁrst used by Godman and Churg.23 Falk named in the classiﬁcation of vasculitis. Rev Bras Reumatol. 2016.
et al.recommended an alternative name for Wegener’s gran-
ulomatosis: Granulomatosis with polyangiitis (Wegener’s).18
Thereafter, ‘Granulomatosis with polyangiitis (Wegener’s)’
instead of ‘Wegener’s granulomatosis’ was used by the CHHC
ARTICLE IN PRESSRBRE-300; No. of Pages 5






















































sr  e v b r a s r e u m a t o l
012.3 It was identiﬁed as Wegener’s in brackets to avoid
onfusion in literature. He received a master clinician prize
rom the American College of Chest Physicians in 1989.24
osen reported at the CHEST in 2007 that the board voted
lmost unanimously to rescind the award.25 He died in 1990,
n Lübeck.14–16
osinophilic  granulomatosis  with  polyangiitis
Churg-Strauss)
osinophilic granulomatosis with polyangiitis (Churg-Strauss)
s ANCA-associated necrotizing granulomatous vasculitis that
ffects predominantly small to medium-size vessels. It is
enerally associated with asthma, paranasal sinusitis, pul-
onary inﬁltrates, neuropathy, and eosinophilia of peripheral
lood or tissue.2,3 The disease is named after Jacob Churg
nd Lotte Strauss. Jacob Churg was a pathologist, born in
910, Dolhinow.26,27 He was interested in medicine since the
ge of eight, worked in the department of internal medicine,
ut was reported as saying ‘I was not very successful with
atients’.27 He then worked as an assistant in the pathol-
gy department of Vilna University. He described a patient
ith asthma, lymphadenopathy, and eosinophilia, who died
f cranial hemorrhage.27 The biopsy specimens of lymph node
howed eosinophilic inﬁltration, early granulomas, vasculi-
is in cranial arteries, and granulomas in various tissues. Dr.
trauss also had similar cases.26 Lotte Strauss was a patholo-
ist, born in 1913in Nuremberg, Germany.26 She specialized
n pediatric and perinatal pathology. They, both reviewed
ases with asthma, fever, and hypereosinophilia. Most of
hem had characteristic, speciﬁc anatomical lesions with
istopathologic entity termed ‘allergic granuloma’. Their article
as published in 1951 entitle ‘Allergic Granulomatosis, Allergic
ngiitis,  and PeriarteritisNodosa’.28 Churg and Strauss described
he entity and called it the Churg-Strauss syndrome. When
earching the term ‘Churg-Strauss syndrome’ on PubMed, we
ound an early article reported by Abul-Haj Sk and Flanagan P,
n 1961 entitled ‘Asthma associated with disseminated necrotizing
ranulomatous vasculitis, the Churg-Strauss syndrome. Report of a
ase’.29 Jacob Churg died in 2005, and Lotte Strauss in 1985.26
gA  vasculitis  (Henoch-Schönlein)
gA vasculitis (Henoch-Schönlein) generally affects small
essels with immunoglobulin A deposits and granulocytes
n the vessels. The clinical features include palpable pur-
ura, arthritis, abdominal pain, gastrointestinal bleeding, and
lomerulonephritis.2,3 The disease is named after Eduard
einrich Henoch and Johann Lukas Schönlein. Eduard Hein-
ich Henoch was a German pediatrician, born in Berlin on
uly 16, 1820, and died in Dresden on August 28, 1910.30,31 He
ompleted his medical education in 1843, and studied with
oritz Romberg and Johann Lukas Schönlein. He worked as
ead of the pediatric clinic of the Royal Charité Hospital. HePlease cite this article in press as: Sargin G, Senturk T. Scientiﬁc people
http://dx.doi.org/10.1016/j.rbre.2016.06.002
ublished his famous textbook called ‘Lectures on Children’s
iseases’.32 On the other hand, he reported a ﬁfteen-year-
ld-male patient with abdominal pain, arthralgia, purpura; a
even-year-old male with purpura, nephritis, and a patient 6;x  x x(x x):xxx–xxx 3
with hematuria and purpura. This article was published in
1868 in the ‘KlinWschr’.33 These ﬁndings were also described by
Johann Lukas Schönlein as an entity. Schönlein was a German
Professor of Internal Medicine, born in Bamberg, Germany on
30 November 1793.34,35 He worked in Würzburg, Zürich, and
Berlin. Schönlein wrote few papers, and described rheumatica
purpura rubra with cutaneous, arthritic symptoms and renal
lesions.36,37 He also described typhoid crystals in patients’
stools, and the causative agent of favus. Johann Lukas Schön-
lein retired in 1859 and died in Bamberg in January 1864.34–36
Variable  vessel  vasculitis
Cogan’s  syndrome
Cogan’s syndrome is a rare chronic inﬂammatory dis-
ease characterized by large to small-sized vessel vasculitis,
nonsyphilitic interstitial keratitis and vestibulo-auditory dys-
function such as tinnitus, hearing loss, and vertigo.3 The
disease is named after David Glendenning Cogan. He was
an American ophthalmologist, born in Massachusetts in
1908.38 He was graduated from the Dartmouth College, Har-
vard University, and continued his career at Harvard Medical
School, Chicago University Clinics, and Massachusetts Eye and
Ear Inﬁrmary. Cogan was certiﬁed by the American Board
of Ophthalmology in 1937, and became a member of the
editorial board at Archives of Ophthalmology, Investigative
Ophthalmology, Albrecht von Graefes Archiv fur Klinische und
Experiementelle Ophthalmologie, and Journal of Neurological
Science.38 In 1945, he reported ﬁve patients with nonsyphilitic
interstitial keratitis and vestibulo-auditory symptoms as a
syndrome at the Archives of Ophthalmology.39 Hence, this clini-
cal entity has come to be called as Cogan’s syndrome. He was
interested in neuro-ophthalmology, and ophthalmic manifes-
tations of systemic vascular disease, and he published many
books on these topics.40,41 He died in Wayne after a heart
attack on September 9, 1993.42
Behc¸et’s  disease
Behc¸et’s disease is a chronic, inﬂammatory, multisystem vas-
culitis and is characterized by recurrent oral ulcers, genital
ulcers, and uveitis.3 The disease generally affect ethnic groups
such Mediterranean and East Asian along the Silk Road. Hulusi
Behc¸et was a Turkish dermatologist, the ﬁrst professor in the
Turkish academic life, born in Istanbul, Turkey on February 20,
1889.43,44 He completed his medical education, and graduated
from Military Medical School in 1910, then worked as an assis-
tant in the Gulhane dermatology clinic until 1914. In July 1914,
he was appointed as Chief Assistant at the Kırklareli Military
Hospital, and worked as a dermatologist at the Edirne Military
Hospital. He also worked at Charité Hospital, Hasköy Derma-
tology and Venereal Diseases Hospital, and Guraba Hospital.45
He was interested in syphilis, leishmaniasis, and mycosis.
Hulusi Behc¸et described two cases with recurrent oral and named in the classiﬁcation of vasculitis. Rev Bras Reumatol. 2016.
genital aphthous ulcers and uveitis with hypopyon. He pub-
lished the ﬁndings and his opinions in 1937 in Dermatologische
Wochenschrift and with more  details in the same journal in
1938.46 The disease was named as ‘Morbus Behc¸et’ by professor
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Mischner in 1947 at the International Medical Congress of
Geneva.45 The disease is encoded as Behc¸et’s disease (M35.2),
at ICD-10 Version:2015.47 He was honored with the TÜBI˙TAK
Science Award in 1975, and Eczacıbas¸ı Science Award in 1982.45
Coins were also produced for his tribute during the National
Dermatology Congress in 1996. Hulusi Behc¸et died in March 8,
1948.43–45
Conclusion
Although the named vasculitis in this article had been previ-
ously described by other valuable scientists, these eponyms
are commonly used in the nomenclature of classiﬁcation of
vasculitis after scientists have honored them. The Ameri-
can College of Rheumatology, the European League Against
Rheumatism, and the American Society of Nephrology rec-
ommend diagnostic terms instead of eponyms such as
Churg-Strauss, Wegener’s etc. Many  new nomenclatures,
and diagnostic terms explain clinico-pathological information
about the disease. As a result, these people who have con-
tributed to science emphasize about the signiﬁcance of clinical
observation, approach and research.
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